VENABLE LLP

VENABLE LLP filed a Q2 report for GENEOSCOPY on July 16, 2026, reporting $20,000 in lobbying income.

Lobbying for GENEOSCOPY · Life sciences company

All filings by VENABLE LLP · Everything GENEOSCOPY has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jul 16, 2026.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Missouri

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Increasing access to colorectal cancer screening Medicare coverage of colorectal cancer screening tests USPSTF colorectal cancer screening guidelines Medicare Quality Measures Commercial coverage of colorectal cancer screening

Budget/Appropriations

FY 2027 LHHS Appropriations regarding colorectal cancer screening

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.